Fortitude Family Office »

Immix Biopharma shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2026-03-31 $482 53 9.11

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Avantis Total Equity Markets Etf Etf (AVTM)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Apple Stock (AAPL)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Mid-cap Etf Etf (VO)
Vanguard S&p 500 Etf Etf (VOO)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Invesco Senior Loan Etf Etf (BKLN)
Avantis International Small Cap Value Etf Etf (AVDV)

View all positions for Fortitude Family Office

Top funds holding Immix Biopharma

Henderson Group
Saturn V Capital Management
Eventide Asset Management
Marshall Wace
Vanguard Capital Management
Millennium Management
Adage Capital Partners GP
Logos Global Management
Vanguard Group
Bleichroeder
Blue Owl Capital Holdings
Franklin Resources
Susquehanna International
BlackRock
Geode Capital Management

View all funds holding Immix Biopharma